Submit a manuscript Sign up for article alerts Contact us Support

About Lipids in Health and Disease

This page includes information about the aims and scope of Lipids in Health and Disease, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors.

Aims & scope

Lipids in Health and Disease is an open access, peer-reviewed, online journal that publishes articles on all aspects of lipids: their biochemistry, pharmacology, toxicology, role in health and disease, and the synthesis of new lipid compounds.

Lipids in Health and Disease is aimed at all scientists, health professionals and physicians interested in the area of lipids. Lipids are defined here in their broadest sense, to include: cholesterol, essential fatty acids, saturated fatty acids, phospholipids, inositol lipids, second messenger lipids, enzymes and synthetic machinery that is involved in the metabolism of various lipids in the cells and tissues, and also various aspects of lipid transport, etc. In addition, the journal also publishes research that investigates and defines the role of lipids in various physiological processes, pathology and disease. In particular, the journal aims to bridge the gap between the bench and the clinic by publishing articles that are particularly relevant to human diseases and the role of lipids in the management of various diseases.

The field of lipid research is expected to have a significant impact in the future of health care. Lipids form an important constituent of all cell membranes, and cellular constituents, and as such they have a profound influence on the interaction of the cell with its immediate environment and the way the messages are received and processed by cells in the body. By regulating cell membrane structure and function, lipids are known to influence the actions of various hormones, peptides and drugs. By emphasizing the clinical relevance of the work on Lipids, the journal aims to bridge the gap between the lab and the clinic.

Open access

All articles published by Lipids in Health and Disease are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.

Authors of articles published in Lipids in Health and Disease are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement.

For authors who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.

Article-processing charges

Open access publishing is not without costs. Lipids in Health and Disease therefore levies an article-processing charge of £1325/$2215/€1600 for each article accepted for publication. If the submitting author's institution is a Member, the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.

Indexing services

All articles published in Lipids in Health and Disease are included in PubMed, the most widely used biomedical bibliographic database service, which is run by the US National Library of Medicine. Other bibliographic databases that index articles published in Lipids in Health and Disease include:

  • CABI
  • CAS
  • Citebase
  • DOAJ
  • Embase
  • EmBiology
  • Food Science and Technology Abstracts
  • Global Health
  • Google Scholar
  • Index Copernicus
  • MEDLINE
  • OAIster
  • PubMed
  • PubMed Central
  • Science Citation Index Expanded
  • SCImago
  • Scopus
  • SOCOLAR
  • Zetoc

The full text of all research articles is deposited in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and other digital archives including e-Depot (The Netherlands).

The full text of all research articles published by BioMed Central is also available on SpringerLink.

Lipids in Health and Disease is tracked by Thomson Reuters (ISI) and has an Impact Factor of 2.02.

Publication and peer review process

Criteria for publication

Lipids in Health and Disease considers the following types of articles:

  • Research: reports of data from original research and clinical trial outcomes.
  • Reviews: comprehensive, authoritative descriptions of any subject within the scope of the journal.
  • Commentaries - short, narrowly focused articles of contemporary interest, usually commissioned by the journal; these are not minireviews. A Commentary generally takes one of two forms:

    1) a discussion of an article or trial that was recently published or that is soon to be published, and that is interesting enough to warrant further comment or explanation. 2) more editorial in nature, this article will cover an aspect of an issue that is relevant to the journal's scope; for example a discussion of the impact of new technology on research and treatment, or a discussion of changes in peer review or grant application procedures and their effect on research.

  • Hypotheses - short articles presenting an untested original hypothesis backed solely by previously published results rather than any new evidence. They should outline significant progress in thinking that would also be testable.
  • Short reports: brief reports of data from original research.

Peer review policies

 

  • Peer review in Lipids in Health and Disease is designed to ensure that the research published is 'good science'.
  • Lipids in Health and Disease considers manuscripts spanning a wide range of scientific interests, as long as the results and conclusions are scientifically justified and not misleading.
  • We recognize the importance of highlighting articles that contain the most interesting, important or significant research. Peer reviewers are asked to indicate articles they consider to be especially interesting or significant. These articles will be given greater prominence within Lipids in Health and Disease and greater external publicity.
  • Two external experts will generally review submitted manuscripts. Peer reviewers will have four possible options, for each article: 1) accept without revision 2) accept after revision without expecting to check those revisions neither accept nor reject until author(s) make revisions and resubmit 3) reject because scientifically unsound

 

Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My Lipids in Health and Disease, a personalized section of the site.

Reprints

High-quality, bound reprints can be purchased for all articles published. Please see our reprints website for further information about ordering reprints.

Supplements

Lipids in Health and Disease will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. All full length articles (proceedings, reviews or research articles) are indexed by PubMed. PubMed displays the title of the supplement only in the case of meeting abstract collections. For further information, please contact us.

Editorial policies

All manuscripts submitted to Lipids in Health and Disease should adhere to BioMed Central's editorial policies.

Citing articles in Lipids in Health and Disease

Articles in Lipids in Health and Disease should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.

Article citations follow this format:

Authors: Title. Lipids Health Dis [year], [volume number]:[article number].

e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Lipids Health Dis 2009, 1:115.

refers to article 115 from Volume 1 of the journal.

Why publish your article in Lipids in Health and Disease?

High visibility

Lipids in Health and Disease's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results.

Speed of publication

Lipids in Health and Disease offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF; the article will then be available through Lipids in Health and Disease, BioMed Central and PubMed Central and will also be included in PubMed.

Flexibility

Online publication in Lipids in Health and Disease gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).

Promotion and press coverage

Articles published in Lipids in Health and Disease are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on Lipids in Health and Disease's pages and on the BioMed Central homepage.

In addition, articles published in Lipids in Health and Disease may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Lipids in Health and Disease. A list of articles recently press-released by journals published by BioMed Central is available here.

Authors of articles published in Lipids in Health and Disease retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the BioMed Central copyright and license agreement).

For further information about the advantages of publishing in a journal from BioMed Central, please click here.